| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 45.868 | 41.140 | 39.829 | 36.926 | 47.413 | 41.545 | 59.815 | 62.196 | 53.389 | 76.849 |
| Total Income - EUR | 45.873 | 41.212 | 39.833 | 36.934 | 47.425 | 42.484 | 60.067 | 62.203 | 53.427 | 76.852 |
| Total Expenses - EUR | 38.632 | 39.101 | 35.732 | 36.412 | 40.533 | 32.272 | 32.993 | 48.696 | 47.300 | 73.025 |
| Gross Profit/Loss - EUR | 7.241 | 2.111 | 4.101 | 522 | 6.892 | 10.212 | 27.074 | 13.507 | 6.127 | 3.826 |
| Net Profit/Loss - EUR | 5.884 | 1.695 | 3.702 | 153 | 6.457 | 9.833 | 26.289 | 12.898 | 5.593 | 2.734 |
| Employees | 3 | 3 | 0 | 4 | 4 | 2 | 3 | 3 | 4 | 7 |
Check the financial reports for the company - Angisand Vet Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.431 | 1.452 | 994 | 593 | 216 | 102 | 700 | 3.931 | 2.892 | 23.669 |
| Current Assets | 17.026 | 9.731 | 16.522 | 12.936 | 20.596 | 23.631 | 29.280 | 16.698 | 23.377 | 16.097 |
| Inventories | 1.368 | 273 | 2.112 | 2.026 | 1.349 | 747 | 4.980 | 7.667 | 16.915 | 5.629 |
| Receivables | 763 | 350 | 1.693 | 350 | 338 | 387 | 4.020 | 1.000 | 1.460 | 4.553 |
| Cash | 14.895 | 9.108 | 12.717 | 10.561 | 18.909 | 22.497 | 20.280 | 8.031 | 5.002 | 5.916 |
| Shareholders Funds | 10.063 | 8.058 | 9.958 | 6.315 | 12.649 | 18.728 | 26.482 | 15.459 | 9.823 | 6.821 |
| Social Capital | 45 | 2.271 | 2.233 | 2.213 | 63 | 62 | 61 | 61 | 61 | 60 |
| Debts | 7.144 | 3.125 | 7.559 | 7.214 | 8.162 | 5.005 | 3.499 | 5.170 | 16.445 | 32.945 |
| Income in Advance | 2.250 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Angisand Vet Srl